nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolpidem—PTGS1—malignant glioma	0.518	1	CbGaD
Zolpidem—CYP1A2—Carmustine—malignant glioma	0.106	0.57	CbGbCtD
Zolpidem—CYP3A4—Temozolomide—malignant glioma	0.0798	0.431	CbGbCtD
Zolpidem—Dysphasia—Temozolomide—malignant glioma	0.00579	0.0314	CcSEcCtD
Zolpidem—Tolmetin—CXCL8—malignant glioma	0.00399	0.555	CrCbGaD
Zolpidem—Paresis—Temozolomide—malignant glioma	0.00346	0.0188	CcSEcCtD
Zolpidem—Abnormal behaviour—Temozolomide—malignant glioma	0.00339	0.0184	CcSEcCtD
Zolpidem—Personality disorder—Carmustine—malignant glioma	0.00302	0.0164	CcSEcCtD
Zolpidem—Altered state of consciousness—Temozolomide—malignant glioma	0.00274	0.0149	CcSEcCtD
Zolpidem—Cerebration impaired—Temozolomide—malignant glioma	0.00215	0.0117	CcSEcCtD
Zolpidem—Haemorrhoids—Temozolomide—malignant glioma	0.00215	0.0117	CcSEcCtD
Zolpidem—Tolmetin—PTGS1—malignant glioma	0.00203	0.283	CrCbGaD
Zolpidem—Aphasia—Carmustine—malignant glioma	0.00202	0.011	CcSEcCtD
Zolpidem—Parosmia—Temozolomide—malignant glioma	0.00195	0.0106	CcSEcCtD
Zolpidem—Aphasia—Temozolomide—malignant glioma	0.00195	0.0106	CcSEcCtD
Zolpidem—Hypokinesia—Carmustine—malignant glioma	0.00194	0.0105	CcSEcCtD
Zolpidem—Burning sensation—Carmustine—malignant glioma	0.00188	0.0102	CcSEcCtD
Zolpidem—Thrombosis—Carmustine—malignant glioma	0.00185	0.01	CcSEcCtD
Zolpidem—Apathy—Temozolomide—malignant glioma	0.00177	0.00961	CcSEcCtD
Zolpidem—Influenza-like symptoms—Temozolomide—malignant glioma	0.00177	0.00961	CcSEcCtD
Zolpidem—Flat affect—Temozolomide—malignant glioma	0.00175	0.00952	CcSEcCtD
Zolpidem—Stupor—Carmustine—malignant glioma	0.00175	0.00951	CcSEcCtD
Zolpidem—Menorrhagia—Temozolomide—malignant glioma	0.00171	0.00927	CcSEcCtD
Zolpidem—Herpes zoster—Temozolomide—malignant glioma	0.00168	0.00912	CcSEcCtD
Zolpidem—Abscess—Carmustine—malignant glioma	0.00165	0.00898	CcSEcCtD
Zolpidem—Otitis media—Temozolomide—malignant glioma	0.00162	0.00882	CcSEcCtD
Zolpidem—Memory impairment—Temozolomide—malignant glioma	0.00161	0.00875	CcSEcCtD
Zolpidem—Rigors—Temozolomide—malignant glioma	0.00155	0.00841	CcSEcCtD
Zolpidem—Speech disorder—Carmustine—malignant glioma	0.00152	0.00826	CcSEcCtD
Zolpidem—Speech disorder—Temozolomide—malignant glioma	0.00147	0.00798	CcSEcCtD
Zolpidem—Disturbance in attention—Temozolomide—malignant glioma	0.00146	0.00792	CcSEcCtD
Zolpidem—Breast pain—Temozolomide—malignant glioma	0.00145	0.00787	CcSEcCtD
Zolpidem—Thinking abnormal—Carmustine—malignant glioma	0.00143	0.00776	CcSEcCtD
Zolpidem—Drug interaction—Carmustine—malignant glioma	0.00141	0.00766	CcSEcCtD
Zolpidem—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00139	0.00755	CcSEcCtD
Zolpidem—Herpes simplex—Temozolomide—malignant glioma	0.00137	0.00745	CcSEcCtD
Zolpidem—Gait disturbance—Carmustine—malignant glioma	0.00134	0.00728	CcSEcCtD
Zolpidem—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00134	0.00726	CcSEcCtD
Zolpidem—Neck pain—Carmustine—malignant glioma	0.00132	0.00719	CcSEcCtD
Zolpidem—Pulmonary embolism—Carmustine—malignant glioma	0.00131	0.0071	CcSEcCtD
Zolpidem—Gait disturbance—Temozolomide—malignant glioma	0.00129	0.00703	CcSEcCtD
Zolpidem—Vaginal inflammation—Temozolomide—malignant glioma	0.00126	0.00686	CcSEcCtD
Zolpidem—Pulmonary embolism—Temozolomide—malignant glioma	0.00126	0.00686	CcSEcCtD
Zolpidem—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00126	0.00686	CcSEcCtD
Zolpidem—Urinary incontinence—Carmustine—malignant glioma	0.00126	0.00686	CcSEcCtD
Zolpidem—Depressed level of consciousness—Carmustine—malignant glioma	0.00126	0.00686	CcSEcCtD
Zolpidem—Neuropathy—Carmustine—malignant glioma	0.00123	0.00667	CcSEcCtD
Zolpidem—Influenza like illness—Temozolomide—malignant glioma	0.00123	0.00667	CcSEcCtD
Zolpidem—Depressed level of consciousness—Temozolomide—malignant glioma	0.00122	0.00663	CcSEcCtD
Zolpidem—Urinary incontinence—Temozolomide—malignant glioma	0.00122	0.00663	CcSEcCtD
Zolpidem—Vaginal infection—Temozolomide—malignant glioma	0.00119	0.00648	CcSEcCtD
Zolpidem—Neuropathy—Temozolomide—malignant glioma	0.00119	0.00644	CcSEcCtD
Zolpidem—Tolmetin—PTGS2—malignant glioma	0.00116	0.162	CrCbGaD
Zolpidem—Abnormal vision—Carmustine—malignant glioma	0.00114	0.00619	CcSEcCtD
Zolpidem—Mental disability—Carmustine—malignant glioma	0.00113	0.00616	CcSEcCtD
Zolpidem—Abnormal vision—Temozolomide—malignant glioma	0.0011	0.00599	CcSEcCtD
Zolpidem—Phlebitis—Carmustine—malignant glioma	0.0011	0.00598	CcSEcCtD
Zolpidem—Mental disability—Temozolomide—malignant glioma	0.0011	0.00596	CcSEcCtD
Zolpidem—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00105	0.00573	CcSEcCtD
Zolpidem—Eye pain—Carmustine—malignant glioma	0.00105	0.00571	CcSEcCtD
Zolpidem—GABRB2—brainstem—malignant glioma	0.00105	0.0386	CbGeAlD
Zolpidem—Gastroenteritis—Temozolomide—malignant glioma	0.00103	0.00562	CcSEcCtD
Zolpidem—Injury—Carmustine—malignant glioma	0.00103	0.00561	CcSEcCtD
Zolpidem—Vascular purpura—Temozolomide—malignant glioma	0.00103	0.00557	CcSEcCtD
Zolpidem—Eye pain—Temozolomide—malignant glioma	0.00102	0.00552	CcSEcCtD
Zolpidem—Amnesia—Carmustine—malignant glioma	0.00101	0.00549	CcSEcCtD
Zolpidem—Hot flush—Temozolomide—malignant glioma	0.00098	0.00533	CcSEcCtD
Zolpidem—PTGS1—endothelium—malignant glioma	0.000978	0.0361	CbGeAlD
Zolpidem—Amnesia—Temozolomide—malignant glioma	0.000976	0.0053	CcSEcCtD
Zolpidem—Menopausal symptoms—Temozolomide—malignant glioma	0.000972	0.00528	CcSEcCtD
Zolpidem—Thirst—Temozolomide—malignant glioma	0.000964	0.00524	CcSEcCtD
Zolpidem—GABRA2—brainstem—malignant glioma	0.000957	0.0353	CbGeAlD
Zolpidem—Purpura—Temozolomide—malignant glioma	0.000951	0.00517	CcSEcCtD
Zolpidem—Diplopia—Carmustine—malignant glioma	0.000949	0.00516	CcSEcCtD
Zolpidem—GABRB2—telencephalon—malignant glioma	0.00093	0.0343	CbGeAlD
Zolpidem—GABRG2—telencephalon—malignant glioma	0.00093	0.0343	CbGeAlD
Zolpidem—GABRA1—brainstem—malignant glioma	0.000925	0.0341	CbGeAlD
Zolpidem—Diplopia—Temozolomide—malignant glioma	0.000917	0.00498	CcSEcCtD
Zolpidem—Face oedema—Carmustine—malignant glioma	0.000916	0.00498	CcSEcCtD
Zolpidem—Affect lability—Temozolomide—malignant glioma	0.000903	0.0049	CcSEcCtD
Zolpidem—PTGS1—blood vessel—malignant glioma	0.000902	0.0333	CbGeAlD
Zolpidem—Ataxia—Carmustine—malignant glioma	0.000892	0.00485	CcSEcCtD
Zolpidem—Face oedema—Temozolomide—malignant glioma	0.000885	0.00481	CcSEcCtD
Zolpidem—Mood swings—Temozolomide—malignant glioma	0.000869	0.00472	CcSEcCtD
Zolpidem—Ataxia—Temozolomide—malignant glioma	0.000862	0.00469	CcSEcCtD
Zolpidem—GABRA2—telencephalon—malignant glioma	0.000849	0.0313	CbGeAlD
Zolpidem—Muscular weakness—Carmustine—malignant glioma	0.000837	0.00455	CcSEcCtD
Zolpidem—Breast disorder—Temozolomide—malignant glioma	0.000829	0.0045	CcSEcCtD
Zolpidem—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000826	0.00449	CcSEcCtD
Zolpidem—GABRA1—telencephalon—malignant glioma	0.000821	0.0303	CbGeAlD
Zolpidem—Dysphagia—Carmustine—malignant glioma	0.00082	0.00446	CcSEcCtD
Zolpidem—Muscular weakness—Temozolomide—malignant glioma	0.000809	0.00439	CcSEcCtD
Zolpidem—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000809	0.00439	CcSEcCtD
Zolpidem—Dysphagia—Temozolomide—malignant glioma	0.000793	0.00431	CcSEcCtD
Zolpidem—Sweating increased—Temozolomide—malignant glioma	0.000772	0.00419	CcSEcCtD
Zolpidem—Bronchitis—Temozolomide—malignant glioma	0.000762	0.00414	CcSEcCtD
Zolpidem—Dysuria—Temozolomide—malignant glioma	0.000741	0.00403	CcSEcCtD
Zolpidem—Hyperglycaemia—Carmustine—malignant glioma	0.00074	0.00402	CcSEcCtD
Zolpidem—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000737	0.004	CcSEcCtD
Zolpidem—Pneumonia—Carmustine—malignant glioma	0.000736	0.004	CcSEcCtD
Zolpidem—Pollakiuria—Temozolomide—malignant glioma	0.000732	0.00398	CcSEcCtD
Zolpidem—GABRB2—medulla oblongata—malignant glioma	0.00073	0.0269	CbGeAlD
Zolpidem—GABRG2—medulla oblongata—malignant glioma	0.00073	0.0269	CbGeAlD
Zolpidem—Erectile dysfunction—Temozolomide—malignant glioma	0.00073	0.00397	CcSEcCtD
Zolpidem—Depression—Carmustine—malignant glioma	0.000729	0.00396	CcSEcCtD
Zolpidem—Photosensitivity reaction—Temozolomide—malignant glioma	0.000723	0.00393	CcSEcCtD
Zolpidem—Weight decreased—Temozolomide—malignant glioma	0.000717	0.0039	CcSEcCtD
Zolpidem—Neuropathy peripheral—Carmustine—malignant glioma	0.000717	0.00389	CcSEcCtD
Zolpidem—Hyperglycaemia—Temozolomide—malignant glioma	0.000715	0.00388	CcSEcCtD
Zolpidem—GABRB3—telencephalon—malignant glioma	0.000714	0.0263	CbGeAlD
Zolpidem—Stomatitis—Carmustine—malignant glioma	0.000713	0.00387	CcSEcCtD
Zolpidem—Urinary tract infection—Carmustine—malignant glioma	0.000711	0.00386	CcSEcCtD
Zolpidem—Pneumonia—Temozolomide—malignant glioma	0.000711	0.00386	CcSEcCtD
Zolpidem—Infestation NOS—Temozolomide—malignant glioma	0.000707	0.00384	CcSEcCtD
Zolpidem—Infestation—Temozolomide—malignant glioma	0.000707	0.00384	CcSEcCtD
Zolpidem—Depression—Temozolomide—malignant glioma	0.000705	0.00383	CcSEcCtD
Zolpidem—Neuropathy peripheral—Temozolomide—malignant glioma	0.000693	0.00376	CcSEcCtD
Zolpidem—Stomatitis—Temozolomide—malignant glioma	0.000689	0.00374	CcSEcCtD
Zolpidem—Urinary tract infection—Temozolomide—malignant glioma	0.000687	0.00373	CcSEcCtD
Zolpidem—GABRB2—midbrain—malignant glioma	0.000668	0.0246	CbGeAlD
Zolpidem—GABRG2—midbrain—malignant glioma	0.000668	0.0246	CbGeAlD
Zolpidem—Sinusitis—Temozolomide—malignant glioma	0.000663	0.0036	CcSEcCtD
Zolpidem—Hypoaesthesia—Carmustine—malignant glioma	0.000653	0.00355	CcSEcCtD
Zolpidem—Hallucination—Carmustine—malignant glioma	0.000653	0.00355	CcSEcCtD
Zolpidem—GABRG2—spinal cord—malignant glioma	0.000651	0.024	CbGeAlD
Zolpidem—GABRB2—spinal cord—malignant glioma	0.000651	0.024	CbGeAlD
Zolpidem—GABRA3—central nervous system—malignant glioma	0.000648	0.0239	CbGeAlD
Zolpidem—Connective tissue disorder—Carmustine—malignant glioma	0.000645	0.00351	CcSEcCtD
Zolpidem—GABRA1—medulla oblongata—malignant glioma	0.000645	0.0238	CbGeAlD
Zolpidem—Visual impairment—Carmustine—malignant glioma	0.000633	0.00344	CcSEcCtD
Zolpidem—Hallucination—Temozolomide—malignant glioma	0.000631	0.00343	CcSEcCtD
Zolpidem—Hypoaesthesia—Temozolomide—malignant glioma	0.000631	0.00343	CcSEcCtD
Zolpidem—Pharyngitis—Temozolomide—malignant glioma	0.00063	0.00342	CcSEcCtD
Zolpidem—Urinary tract disorder—Temozolomide—malignant glioma	0.000627	0.0034	CcSEcCtD
Zolpidem—Connective tissue disorder—Temozolomide—malignant glioma	0.000623	0.00339	CcSEcCtD
Zolpidem—Urethral disorder—Temozolomide—malignant glioma	0.000622	0.00338	CcSEcCtD
Zolpidem—Eye disorder—Carmustine—malignant glioma	0.000614	0.00333	CcSEcCtD
Zolpidem—Visual impairment—Temozolomide—malignant glioma	0.000611	0.00332	CcSEcCtD
Zolpidem—Flushing—Carmustine—malignant glioma	0.000609	0.00331	CcSEcCtD
Zolpidem—Eye disorder—Temozolomide—malignant glioma	0.000593	0.00322	CcSEcCtD
Zolpidem—Tinnitus—Temozolomide—malignant glioma	0.000592	0.00321	CcSEcCtD
Zolpidem—GABRA1—midbrain—malignant glioma	0.000589	0.0217	CbGeAlD
Zolpidem—Flushing—Temozolomide—malignant glioma	0.000589	0.0032	CcSEcCtD
Zolpidem—Cardiac disorder—Temozolomide—malignant glioma	0.000589	0.0032	CcSEcCtD
Zolpidem—Arrhythmia—Carmustine—malignant glioma	0.000586	0.00319	CcSEcCtD
Zolpidem—Mental disorder—Carmustine—malignant glioma	0.000575	0.00312	CcSEcCtD
Zolpidem—GABRA1—spinal cord—malignant glioma	0.000575	0.0212	CbGeAlD
Zolpidem—Mediastinal disorder—Temozolomide—malignant glioma	0.000572	0.00311	CcSEcCtD
Zolpidem—Erythema—Carmustine—malignant glioma	0.000571	0.0031	CcSEcCtD
Zolpidem—Malnutrition—Carmustine—malignant glioma	0.000571	0.0031	CcSEcCtD
Zolpidem—Chills—Temozolomide—malignant glioma	0.000569	0.00309	CcSEcCtD
Zolpidem—GABRB3—medulla oblongata—malignant glioma	0.000561	0.0207	CbGeAlD
Zolpidem—Mental disorder—Temozolomide—malignant glioma	0.000556	0.00302	CcSEcCtD
Zolpidem—Back pain—Carmustine—malignant glioma	0.000553	0.003	CcSEcCtD
Zolpidem—Malnutrition—Temozolomide—malignant glioma	0.000552	0.003	CcSEcCtD
Zolpidem—Erythema—Temozolomide—malignant glioma	0.000552	0.003	CcSEcCtD
Zolpidem—Dysgeusia—Temozolomide—malignant glioma	0.000541	0.00294	CcSEcCtD
Zolpidem—Vision blurred—Carmustine—malignant glioma	0.000539	0.00293	CcSEcCtD
Zolpidem—Tremor—Carmustine—malignant glioma	0.000535	0.00291	CcSEcCtD
Zolpidem—Back pain—Temozolomide—malignant glioma	0.000534	0.0029	CcSEcCtD
Zolpidem—GABRB2—central nervous system—malignant glioma	0.000528	0.0195	CbGeAlD
Zolpidem—GABRG2—central nervous system—malignant glioma	0.000528	0.0195	CbGeAlD
Zolpidem—Anaemia—Carmustine—malignant glioma	0.000528	0.00287	CcSEcCtD
Zolpidem—Agitation—Carmustine—malignant glioma	0.000525	0.00285	CcSEcCtD
Zolpidem—Vision blurred—Temozolomide—malignant glioma	0.00052	0.00283	CcSEcCtD
Zolpidem—Tremor—Temozolomide—malignant glioma	0.000517	0.00281	CcSEcCtD
Zolpidem—GABRB2—cerebellum—malignant glioma	0.000516	0.0191	CbGeAlD
Zolpidem—GABRG2—cerebellum—malignant glioma	0.000516	0.0191	CbGeAlD
Zolpidem—GABRA3—brain—malignant glioma	0.000515	0.019	CbGeAlD
Zolpidem—GABRB3—midbrain—malignant glioma	0.000513	0.0189	CbGeAlD
Zolpidem—Ill-defined disorder—Temozolomide—malignant glioma	0.000512	0.00278	CcSEcCtD
Zolpidem—Leukopenia—Carmustine—malignant glioma	0.000512	0.00278	CcSEcCtD
Zolpidem—Anaemia—Temozolomide—malignant glioma	0.00051	0.00277	CcSEcCtD
Zolpidem—Agitation—Temozolomide—malignant glioma	0.000508	0.00276	CcSEcCtD
Zolpidem—Angioedema—Temozolomide—malignant glioma	0.000505	0.00274	CcSEcCtD
Zolpidem—GABRB3—spinal cord—malignant glioma	0.0005	0.0185	CbGeAlD
Zolpidem—Malaise—Temozolomide—malignant glioma	0.000498	0.00271	CcSEcCtD
Zolpidem—Vertigo—Temozolomide—malignant glioma	0.000496	0.0027	CcSEcCtD
Zolpidem—Leukopenia—Temozolomide—malignant glioma	0.000494	0.00269	CcSEcCtD
Zolpidem—Hypertension—Carmustine—malignant glioma	0.000493	0.00268	CcSEcCtD
Zolpidem—Palpitations—Temozolomide—malignant glioma	0.000488	0.00265	CcSEcCtD
Zolpidem—Myalgia—Carmustine—malignant glioma	0.000487	0.00264	CcSEcCtD
Zolpidem—Chest pain—Carmustine—malignant glioma	0.000487	0.00264	CcSEcCtD
Zolpidem—Anxiety—Carmustine—malignant glioma	0.000485	0.00263	CcSEcCtD
Zolpidem—GABRA2—central nervous system—malignant glioma	0.000483	0.0178	CbGeAlD
Zolpidem—Cough—Temozolomide—malignant glioma	0.000482	0.00262	CcSEcCtD
Zolpidem—Hypertension—Temozolomide—malignant glioma	0.000477	0.00259	CcSEcCtD
Zolpidem—GABRA2—cerebellum—malignant glioma	0.000472	0.0174	CbGeAlD
Zolpidem—Confusional state—Carmustine—malignant glioma	0.00047	0.00256	CcSEcCtD
Zolpidem—Myalgia—Temozolomide—malignant glioma	0.00047	0.00255	CcSEcCtD
Zolpidem—Arthralgia—Temozolomide—malignant glioma	0.00047	0.00255	CcSEcCtD
Zolpidem—Anxiety—Temozolomide—malignant glioma	0.000469	0.00255	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000467	0.00254	CcSEcCtD
Zolpidem—GABRA1—central nervous system—malignant glioma	0.000467	0.0172	CbGeAlD
Zolpidem—Oedema—Carmustine—malignant glioma	0.000466	0.00253	CcSEcCtD
Zolpidem—Discomfort—Temozolomide—malignant glioma	0.000465	0.00252	CcSEcCtD
Zolpidem—Infection—Carmustine—malignant glioma	0.000463	0.00252	CcSEcCtD
Zolpidem—Dry mouth—Temozolomide—malignant glioma	0.00046	0.0025	CcSEcCtD
Zolpidem—GABRA1—cerebellum—malignant glioma	0.000456	0.0168	CbGeAlD
Zolpidem—Tachycardia—Carmustine—malignant glioma	0.000455	0.00247	CcSEcCtD
Zolpidem—Confusional state—Temozolomide—malignant glioma	0.000454	0.00247	CcSEcCtD
Zolpidem—Anaphylactic shock—Temozolomide—malignant glioma	0.000451	0.00245	CcSEcCtD
Zolpidem—Oedema—Temozolomide—malignant glioma	0.000451	0.00245	CcSEcCtD
Zolpidem—Infection—Temozolomide—malignant glioma	0.000448	0.00243	CcSEcCtD
Zolpidem—Anorexia—Carmustine—malignant glioma	0.000445	0.00242	CcSEcCtD
Zolpidem—Nervous system disorder—Temozolomide—malignant glioma	0.000442	0.0024	CcSEcCtD
Zolpidem—Skin disorder—Temozolomide—malignant glioma	0.000438	0.00238	CcSEcCtD
Zolpidem—PTGS1—telencephalon—malignant glioma	0.000438	0.0161	CbGeAlD
Zolpidem—Hypotension—Carmustine—malignant glioma	0.000436	0.00237	CcSEcCtD
Zolpidem—Hyperhidrosis—Temozolomide—malignant glioma	0.000436	0.00237	CcSEcCtD
Zolpidem—Anorexia—Temozolomide—malignant glioma	0.00043	0.00233	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000425	0.00231	CcSEcCtD
Zolpidem—Insomnia—Carmustine—malignant glioma	0.000422	0.00229	CcSEcCtD
Zolpidem—GABRG2—brain—malignant glioma	0.000419	0.0155	CbGeAlD
Zolpidem—GABRB2—brain—malignant glioma	0.000419	0.0155	CbGeAlD
Zolpidem—Paraesthesia—Carmustine—malignant glioma	0.000419	0.00228	CcSEcCtD
Zolpidem—Dyspnoea—Carmustine—malignant glioma	0.000416	0.00226	CcSEcCtD
Zolpidem—Somnolence—Carmustine—malignant glioma	0.000415	0.00225	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000411	0.00223	CcSEcCtD
Zolpidem—Insomnia—Temozolomide—malignant glioma	0.000408	0.00221	CcSEcCtD
Zolpidem—GABRB3—central nervous system—malignant glioma	0.000406	0.015	CbGeAlD
Zolpidem—Decreased appetite—Carmustine—malignant glioma	0.000405	0.0022	CcSEcCtD
Zolpidem—CYP2D6—brainstem—malignant glioma	0.000405	0.015	CbGeAlD
Zolpidem—Paraesthesia—Temozolomide—malignant glioma	0.000405	0.0022	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Carmustine—malignant glioma	0.000403	0.00219	CcSEcCtD
Zolpidem—Dyspnoea—Temozolomide—malignant glioma	0.000402	0.00218	CcSEcCtD
Zolpidem—Somnolence—Temozolomide—malignant glioma	0.000401	0.00218	CcSEcCtD
Zolpidem—Pain—Carmustine—malignant glioma	0.000399	0.00217	CcSEcCtD
Zolpidem—Constipation—Carmustine—malignant glioma	0.000399	0.00217	CcSEcCtD
Zolpidem—Dyspepsia—Temozolomide—malignant glioma	0.000397	0.00216	CcSEcCtD
Zolpidem—GABRB3—cerebellum—malignant glioma	0.000397	0.0146	CbGeAlD
Zolpidem—Decreased appetite—Temozolomide—malignant glioma	0.000392	0.00213	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000389	0.00211	CcSEcCtD
Zolpidem—Fatigue—Temozolomide—malignant glioma	0.000389	0.00211	CcSEcCtD
Zolpidem—Pain—Temozolomide—malignant glioma	0.000385	0.00209	CcSEcCtD
Zolpidem—Constipation—Temozolomide—malignant glioma	0.000385	0.00209	CcSEcCtD
Zolpidem—Feeling abnormal—Carmustine—malignant glioma	0.000384	0.00209	CcSEcCtD
Zolpidem—GABRA2—brain—malignant glioma	0.000383	0.0141	CbGeAlD
Zolpidem—Gastrointestinal pain—Carmustine—malignant glioma	0.000381	0.00207	CcSEcCtD
Zolpidem—Feeling abnormal—Temozolomide—malignant glioma	0.000371	0.00202	CcSEcCtD
Zolpidem—GABRA1—brain—malignant glioma	0.00037	0.0137	CbGeAlD
Zolpidem—Body temperature increased—Carmustine—malignant glioma	0.000369	0.002	CcSEcCtD
Zolpidem—Abdominal pain—Carmustine—malignant glioma	0.000369	0.002	CcSEcCtD
Zolpidem—Gastrointestinal pain—Temozolomide—malignant glioma	0.000369	0.002	CcSEcCtD
Zolpidem—CYP2D6—telencephalon—malignant glioma	0.00036	0.0133	CbGeAlD
Zolpidem—Urticaria—Temozolomide—malignant glioma	0.000358	0.00195	CcSEcCtD
Zolpidem—Body temperature increased—Temozolomide—malignant glioma	0.000356	0.00194	CcSEcCtD
Zolpidem—Abdominal pain—Temozolomide—malignant glioma	0.000356	0.00194	CcSEcCtD
Zolpidem—Hypersensitivity—Carmustine—malignant glioma	0.000344	0.00187	CcSEcCtD
Zolpidem—Asthenia—Carmustine—malignant glioma	0.000335	0.00182	CcSEcCtD
Zolpidem—Hypersensitivity—Temozolomide—malignant glioma	0.000332	0.0018	CcSEcCtD
Zolpidem—Asthenia—Temozolomide—malignant glioma	0.000323	0.00176	CcSEcCtD
Zolpidem—GABRB3—brain—malignant glioma	0.000322	0.0119	CbGeAlD
Zolpidem—Diarrhoea—Carmustine—malignant glioma	0.000319	0.00173	CcSEcCtD
Zolpidem—Pruritus—Temozolomide—malignant glioma	0.000319	0.00173	CcSEcCtD
Zolpidem—Dizziness—Carmustine—malignant glioma	0.000308	0.00168	CcSEcCtD
Zolpidem—Diarrhoea—Temozolomide—malignant glioma	0.000308	0.00168	CcSEcCtD
Zolpidem—PTGS1—spinal cord—malignant glioma	0.000307	0.0113	CbGeAlD
Zolpidem—Dizziness—Temozolomide—malignant glioma	0.000298	0.00162	CcSEcCtD
Zolpidem—Vomiting—Carmustine—malignant glioma	0.000297	0.00161	CcSEcCtD
Zolpidem—Rash—Carmustine—malignant glioma	0.000294	0.0016	CcSEcCtD
Zolpidem—Dermatitis—Carmustine—malignant glioma	0.000294	0.0016	CcSEcCtD
Zolpidem—Headache—Carmustine—malignant glioma	0.000292	0.00159	CcSEcCtD
Zolpidem—Vomiting—Temozolomide—malignant glioma	0.000287	0.00156	CcSEcCtD
Zolpidem—Rash—Temozolomide—malignant glioma	0.000284	0.00154	CcSEcCtD
Zolpidem—Dermatitis—Temozolomide—malignant glioma	0.000284	0.00154	CcSEcCtD
Zolpidem—Headache—Temozolomide—malignant glioma	0.000282	0.00153	CcSEcCtD
Zolpidem—Nausea—Carmustine—malignant glioma	0.000277	0.00151	CcSEcCtD
Zolpidem—Nausea—Temozolomide—malignant glioma	0.000268	0.00145	CcSEcCtD
Zolpidem—PTGS1—central nervous system—malignant glioma	0.000249	0.00917	CbGeAlD
Zolpidem—CYP3A4—central nervous system—malignant glioma	0.000208	0.00766	CbGeAlD
Zolpidem—CYP2D6—central nervous system—malignant glioma	0.000204	0.00754	CbGeAlD
Zolpidem—CYP2D6—cerebellum—malignant glioma	0.0002	0.00737	CbGeAlD
Zolpidem—PTGS1—brain—malignant glioma	0.000197	0.00728	CbGeAlD
Zolpidem—CYP2D6—brain—malignant glioma	0.000162	0.00599	CbGeAlD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	4.13e-05	0.000525	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—GSTP1—malignant glioma	4.11e-05	0.000523	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	4.1e-05	0.000521	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	4.05e-05	0.000515	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—COX8A—malignant glioma	3.96e-05	0.000504	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—TNF—malignant glioma	3.88e-05	0.000494	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	3.81e-05	0.000485	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—MDM2—malignant glioma	3.75e-05	0.000476	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—RAF1—malignant glioma	3.73e-05	0.000475	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	3.69e-05	0.000469	CbGpPWpGaD
Zolpidem—GABRB3—BDNF signaling pathway—AKT1—malignant glioma	3.59e-05	0.000456	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—IDH2—malignant glioma	3.53e-05	0.000449	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	3.48e-05	0.000442	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—IDH2—malignant glioma	3.42e-05	0.000435	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—ASMT—malignant glioma	3.37e-05	0.000428	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	3.36e-05	0.000428	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CYP2B6—malignant glioma	3.32e-05	0.000422	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.23e-05	0.000411	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CYP2B6—malignant glioma	3.22e-05	0.000409	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—RTEL1—malignant glioma	3.21e-05	0.000408	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—GSTP1—malignant glioma	3.17e-05	0.000403	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—BCAN—malignant glioma	3.17e-05	0.000403	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	3.13e-05	0.000398	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—COX8A—malignant glioma	3.06e-05	0.00039	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—IDH1—malignant glioma	3.04e-05	0.000386	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	2.97e-05	0.000378	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—IDH1—malignant glioma	2.94e-05	0.000374	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—SPHK1—malignant glioma	2.94e-05	0.000374	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CYP2C18—malignant glioma	2.88e-05	0.000366	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	2.87e-05	0.000365	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—SPHK1—malignant glioma	2.85e-05	0.000362	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—COX8A—malignant glioma	2.82e-05	0.000358	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—COX8A—malignant glioma	2.79e-05	0.000355	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CYP2C18—malignant glioma	2.79e-05	0.000355	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.74e-05	0.000348	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.63e-05	0.000335	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—ASMT—malignant glioma	2.61e-05	0.000331	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—IDH2—malignant glioma	2.55e-05	0.000325	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.55e-05	0.000324	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—RAF1—malignant glioma	2.51e-05	0.000319	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.5e-05	0.000317	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—BCAN—malignant glioma	2.45e-05	0.000311	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CYP2B6—malignant glioma	2.4e-05	0.000305	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.4e-05	0.000305	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—ASMT—malignant glioma	2.4e-05	0.000305	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—RAF1—malignant glioma	2.4e-05	0.000305	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—COX8A—malignant glioma	2.39e-05	0.000304	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—ASMT—malignant glioma	2.38e-05	0.000302	CbGpPWpGaD
Zolpidem—GABRA2—Transmembrane transport of small molecules—RAF1—malignant glioma	2.35e-05	0.000299	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—RAF1—malignant glioma	2.34e-05	0.000297	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—GSTT1—malignant glioma	2.33e-05	0.000296	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.32e-05	0.000295	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.31e-05	0.000294	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—RAF1—malignant glioma	2.3e-05	0.000292	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—GSTT1—malignant glioma	2.26e-05	0.000287	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—BCAN—malignant glioma	2.25e-05	0.000286	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—BCAN—malignant glioma	2.23e-05	0.000284	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—IDH1—malignant glioma	2.2e-05	0.000279	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PTGS1—malignant glioma	2.18e-05	0.000277	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.13e-05	0.000271	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—SPHK1—malignant glioma	2.12e-05	0.00027	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.11e-05	0.000268	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CYP2C18—malignant glioma	2.08e-05	0.000265	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—ASMT—malignant glioma	2.03e-05	0.000258	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—BCHE—malignant glioma	2.03e-05	0.000258	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.01e-05	0.000255	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—SLC5A5—malignant glioma	2e-05	0.000255	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.98e-05	0.000252	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—IDH2—malignant glioma	1.97e-05	0.000251	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—BCHE—malignant glioma	1.97e-05	0.00025	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—SLC5A5—malignant glioma	1.94e-05	0.000247	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—BCAN—malignant glioma	1.91e-05	0.000243	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.86e-05	0.000237	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CYP2B6—malignant glioma	1.86e-05	0.000236	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—COX8A—malignant glioma	1.84e-05	0.000234	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.84e-05	0.000234	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.82e-05	0.000231	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—IDH2—malignant glioma	1.82e-05	0.000231	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—IDH2—malignant glioma	1.8e-05	0.000229	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CYP2B6—malignant glioma	1.71e-05	0.000217	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—IDH1—malignant glioma	1.7e-05	0.000216	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.7e-05	0.000216	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.69e-05	0.000215	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—GSTT1—malignant glioma	1.68e-05	0.000214	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—SPHK1—malignant glioma	1.64e-05	0.000209	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—GSTP1—malignant glioma	1.61e-05	0.000205	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CYP2C18—malignant glioma	1.61e-05	0.000205	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.59e-05	0.000202	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PTGS1—malignant glioma	1.58e-05	0.000201	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CAT—malignant glioma	1.57e-05	0.0002	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—ASMT—malignant glioma	1.57e-05	0.000199	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—GSTP1—malignant glioma	1.56e-05	0.000199	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—IDH1—malignant glioma	1.56e-05	0.000199	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—IDH1—malignant glioma	1.55e-05	0.000197	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—IDH2—malignant glioma	1.54e-05	0.000196	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CAT—malignant glioma	1.52e-05	0.000194	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.52e-05	0.000193	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—SPHK1—malignant glioma	1.51e-05	0.000192	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—SPHK1—malignant glioma	1.5e-05	0.00019	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—NCOR1—malignant glioma	1.48e-05	0.000189	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.48e-05	0.000188	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—BCAN—malignant glioma	1.47e-05	0.000187	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.47e-05	0.000187	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—BCHE—malignant glioma	1.47e-05	0.000186	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.45e-05	0.000184	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—SLC5A5—malignant glioma	1.45e-05	0.000184	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.45e-05	0.000184	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—NCOR1—malignant glioma	1.44e-05	0.000183	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.38e-05	0.000176	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.38e-05	0.000176	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.33e-05	0.00017	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—IDH1—malignant glioma	1.32e-05	0.000168	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GSTT1—malignant glioma	1.3e-05	0.000165	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—SPHK1—malignant glioma	1.28e-05	0.000163	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.26e-05	0.00016	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CYP2C18—malignant glioma	1.25e-05	0.000159	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PTGS1—malignant glioma	1.22e-05	0.000155	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.22e-05	0.000155	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.22e-05	0.000155	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CAV1—malignant glioma	1.21e-05	0.000154	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GSTT1—malignant glioma	1.2e-05	0.000152	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—IDH2—malignant glioma	1.19e-05	0.000151	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GSTT1—malignant glioma	1.19e-05	0.000151	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.18e-05	0.00015	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CAV1—malignant glioma	1.17e-05	0.000149	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—GSTP1—malignant glioma	1.17e-05	0.000148	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CAT—malignant glioma	1.14e-05	0.000144	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—BCHE—malignant glioma	1.13e-05	0.000144	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PTGS1—malignant glioma	1.12e-05	0.000143	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—SLC5A5—malignant glioma	1.12e-05	0.000142	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.12e-05	0.000142	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.12e-05	0.000142	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PTGS1—malignant glioma	1.11e-05	0.000141	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.11e-05	0.000141	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PIK3CG—malignant glioma	1.1e-05	0.00014	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.08e-05	0.000137	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—NCOR1—malignant glioma	1.07e-05	0.000136	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PIK3CG—malignant glioma	1.07e-05	0.000136	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PPARG—malignant glioma	1.06e-05	0.000135	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.06e-05	0.000135	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.05e-05	0.000133	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—BCHE—malignant glioma	1.04e-05	0.000133	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.04e-05	0.000132	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—BCHE—malignant glioma	1.03e-05	0.000131	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PPARG—malignant glioma	1.03e-05	0.000131	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.03e-05	0.000131	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.02e-05	0.00013	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—IDH1—malignant glioma	1.02e-05	0.00013	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GSTT1—malignant glioma	1.01e-05	0.000129	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—SPHK1—malignant glioma	9.88e-06	0.000126	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PIK3CD—malignant glioma	9.68e-06	0.000123	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CYP2C18—malignant glioma	9.68e-06	0.000123	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.66e-06	0.000123	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.57e-06	0.000122	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PTGS1—malignant glioma	9.5e-06	0.000121	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.47e-06	0.00012	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PIK3CD—malignant glioma	9.39e-06	0.000119	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.15e-06	0.000116	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—GSTP1—malignant glioma	9.02e-06	0.000115	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—BCHE—malignant glioma	8.84e-06	0.000112	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CAT—malignant glioma	8.78e-06	0.000112	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CAV1—malignant glioma	8.74e-06	0.000111	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—SLC5A5—malignant glioma	8.73e-06	0.000111	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PIK3CB—malignant glioma	8.44e-06	0.000107	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PTGS2—malignant glioma	8.36e-06	0.000106	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.35e-06	0.000106	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—GSTP1—malignant glioma	8.3e-06	0.000106	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—NCOR1—malignant glioma	8.29e-06	0.000105	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.25e-06	0.000105	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—GSTP1—malignant glioma	8.23e-06	0.000105	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PIK3CB—malignant glioma	8.18e-06	0.000104	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.18e-06	0.000104	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PTGS2—malignant glioma	8.11e-06	0.000103	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CAT—malignant glioma	8.07e-06	0.000103	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CAT—malignant glioma	8.01e-06	0.000102	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PIK3CG—malignant glioma	7.96e-06	0.000101	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GSTT1—malignant glioma	7.83e-06	9.95e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PPARG—malignant glioma	7.69e-06	9.77e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—NCOR1—malignant glioma	7.63e-06	9.7e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—NCOR1—malignant glioma	7.56e-06	9.61e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PTGS1—malignant glioma	7.33e-06	9.33e-05	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PTEN—malignant glioma	7.29e-06	9.27e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.13e-06	9.07e-05	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PTEN—malignant glioma	7.07e-06	8.99e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—GSTP1—malignant glioma	7.03e-06	8.94e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PIK3CD—malignant glioma	7e-06	8.9e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CAT—malignant glioma	6.84e-06	8.7e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—BCHE—malignant glioma	6.82e-06	8.67e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CAV1—malignant glioma	6.76e-06	8.59e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—SLC5A5—malignant glioma	6.74e-06	8.56e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—NCOR1—malignant glioma	6.46e-06	8.21e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.46e-06	8.21e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CAV1—malignant glioma	6.22e-06	7.9e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CAV1—malignant glioma	6.16e-06	7.84e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PIK3CG—malignant glioma	6.16e-06	7.83e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PIK3CB—malignant glioma	6.1e-06	7.76e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PTGS2—malignant glioma	6.05e-06	7.69e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PPARG—malignant glioma	5.94e-06	7.55e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.89e-06	7.49e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PIK3CG—malignant glioma	5.66e-06	7.2e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PIK3CG—malignant glioma	5.61e-06	7.14e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PPARG—malignant glioma	5.46e-06	6.95e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—GSTP1—malignant glioma	5.43e-06	6.9e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PPARG—malignant glioma	5.42e-06	6.89e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PIK3CD—malignant glioma	5.41e-06	6.88e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CAT—malignant glioma	5.28e-06	6.71e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PTEN—malignant glioma	5.27e-06	6.7e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CAV1—malignant glioma	5.27e-06	6.7e-05	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—PIK3CA—malignant glioma	5.15e-06	6.54e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.03e-06	6.4e-05	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—PIK3CA—malignant glioma	4.99e-06	6.34e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—NCOR1—malignant glioma	4.99e-06	6.34e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.98e-06	6.33e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PIK3CD—malignant glioma	4.93e-06	6.27e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PIK3CG—malignant glioma	4.8e-06	6.1e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PIK3CB—malignant glioma	4.72e-06	6e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PTGS2—malignant glioma	4.67e-06	5.94e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PPARG—malignant glioma	4.63e-06	5.89e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PIK3CB—malignant glioma	4.34e-06	5.52e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PIK3CB—malignant glioma	4.3e-06	5.47e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PTGS2—malignant glioma	4.3e-06	5.47e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PTGS2—malignant glioma	4.26e-06	5.42e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PIK3CD—malignant glioma	4.22e-06	5.36e-05	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—AKT1—malignant glioma	4.2e-06	5.34e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PTEN—malignant glioma	4.08e-06	5.18e-05	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—AKT1—malignant glioma	4.07e-06	5.18e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CAV1—malignant glioma	4.06e-06	5.17e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PTEN—malignant glioma	3.75e-06	4.77e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—PIK3CA—malignant glioma	3.72e-06	4.73e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PTEN—malignant glioma	3.72e-06	4.73e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.7e-06	4.71e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PIK3CB—malignant glioma	3.68e-06	4.67e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PTGS2—malignant glioma	3.64e-06	4.63e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PPARG—malignant glioma	3.57e-06	4.54e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.25e-06	4.14e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PTEN—malignant glioma	3.18e-06	4.04e-05	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—AKT1—malignant glioma	3.04e-06	3.86e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.88e-06	3.66e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.84e-06	3.61e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PTGS2—malignant glioma	2.81e-06	3.57e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.64e-06	3.36e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.62e-06	3.33e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PTEN—malignant glioma	2.45e-06	3.12e-05	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—AKT1—malignant glioma	2.35e-06	2.99e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—PIK3CA—malignant glioma	2.24e-06	2.85e-05	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—AKT1—malignant glioma	2.16e-06	2.75e-05	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—AKT1—malignant glioma	2.14e-06	2.72e-05	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—AKT1—malignant glioma	1.83e-06	2.33e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.73e-06	2.2e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—AKT1—malignant glioma	1.41e-06	1.8e-05	CbGpPWpGaD
